Skip to content
Clinical Trials – home
PolandBack to Poland

Clinical trials in Stalowa Wola

3 clinical trials in Stalowa Wola, Poland. Every trial is listed in the EU Clinical Trials Register and updated daily.

PolandOur site in PolandBadaniaKliniczne.pl(opens in a new tab)
Stalowa Wola at a glance
3
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

3 trials in Stalowa Wola

Open in trial search
Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Clazakizumab
  • Sponsor:CSL Behring LLC
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Etanercept
  • Sponsor:Mabxience Research S.L.
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Human Serum Albumin
  • Sponsor:Instituto Grifols S.A.

Other cities in Poland

The busiest research cities in the country

All 239 cities in Poland

Clinical research in Stalowa Wola

What the registry says about research in the country

01 Liver Disease Research

Clinical trials focusing on Acute-On-Chronic Liver Failure (ACLF) are evaluating innovative treatment approaches combining standard medical therapy with plasma exchange to improve survival rates in high-risk patients.

  • ACLF Management
  • Hospital Mortality Prevention
  • Plasma Exchange Therapy

Research aims to enhance outcomes for patients with various stages of liver failure complications.

02 Rheumatology Studies

Innovative research in rheumatoid arthritis treatment is comparing the effectiveness of biosimilar medications to established therapies, focusing on patients with moderate to severe symptoms.

  • Biosimilar Evaluation
  • Treatment Response Assessment
  • Immunogenicity Studies

These trials aim to expand treatment options while maintaining therapeutic effectiveness.

03 Cardiovascular Research

Studies addressing atherosclerotic cardiovascular disease in dialysis patients are exploring new therapeutic approaches using targeted biological treatments to reduce inflammation markers.

  • ESKD Management
  • Cardiovascular Outcomes
  • Inflammation Control

Research focuses on improving cardiovascular health in end-stage kidney disease patients.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.